![Robert E. Ward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert E. Ward
Direttore/Membro del Consiglio presso Massachusetts High Technology Council, Inc.
Posizioni attive di Robert E. Ward
Società | Posizione | Inizio | Fine |
---|---|---|---|
Massachusetts High Technology Council, Inc.
![]() Massachusetts High Technology Council, Inc. Internet Software/ServicesTechnology Services Massachusetts High Technology Council is an organization that advocates for public policies and programs that create and maintain a competitive business climate. The non-profit company is based in Waltham, MA. The company has been nurturing tech companies for over 70 years, despite its reputation as a high-tax expensive place to do business. The Massachusetts High Technology Council provides resources and hosts events for its members, and offers membership to organizations that want to join other thought leaders in the Commonwealth. Massachusetts High Technology Council Member Testimonials are available on their website. The company was founded by Raymond S. Stata. | Direttore/Membro del Consiglio | - | - |
Antidote Therapeutics, Inc.
![]() Antidote Therapeutics, Inc. BiotechnologyHealth Technology Antidote Therapeutics, Inc. engages in the provision of nicotine-blocking drugs to treat diseases caused or worsened by nicotine. Its product pipeline include ATI-1013, ATI 3009, and ATI-2000. The company was founded by Matthew Kalnik and is headquartered in Gaithersburg, MD. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Robert E. Ward
Precedenti posizioni note di Robert E. Ward
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONCOSEC MEDICAL INCORPORATED | Direttore/Membro del Consiglio | 08/11/2018 | 23/11/2021 |
Independent Dir/Board Member | 08/11/2018 | 23/11/2021 | |
ELOXX PHARMACEUTICALS, INC. | Amministratore Delegato | 26/12/2017 | 29/02/2020 |
Presidente | 26/12/2017 | 29/02/2020 | |
AKARI THERAPEUTICS, PLC | Direttore/Membro del Consiglio | 14/10/2016 | 01/08/2018 |
Independent Dir/Board Member | 14/10/2016 | 01/08/2018 | |
RADIUS HEALTH, INC. | Direttore/Membro del Consiglio | 16/12/2013 | 17/07/2017 |
Amministratore Delegato | 16/12/2013 | 17/07/2017 | |
Presidente | 16/12/2013 | 17/07/2017 | |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2011 | 01/12/2013 |
Harriman Biopartners LLC | Corporate Officer/Principal | 01/01/2010 | 01/01/2011 |
NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2006 | 01/01/2010 |
░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
Formazione di Robert E. Ward
University of California, Santa Barbara | Undergraduate Degree |
New Jersey Institute of Technology | Graduate Degree |
The Johns Hopkins University School of Medicine | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Regno Unito | 3 |
Posizioni
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
ASTRAZENECA PLC | Health Technology |
ONCOSEC MEDICAL INCORPORATED | Health Services |
CLARKSON PLC | Transportation |
AKARI THERAPEUTICS, PLC | Health Technology |
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
NPS Pharmaceuticals, Inc.
![]() NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Radius Health, Inc.
![]() Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Massachusetts High Technology Council, Inc.
![]() Massachusetts High Technology Council, Inc. Internet Software/ServicesTechnology Services Massachusetts High Technology Council is an organization that advocates for public policies and programs that create and maintain a competitive business climate. The non-profit company is based in Waltham, MA. The company has been nurturing tech companies for over 70 years, despite its reputation as a high-tax expensive place to do business. The Massachusetts High Technology Council provides resources and hosts events for its members, and offers membership to organizations that want to join other thought leaders in the Commonwealth. Massachusetts High Technology Council Member Testimonials are available on their website. The company was founded by Raymond S. Stata. | Technology Services |
Harriman Biopartners LLC | |
Antidote Therapeutics, Inc.
![]() Antidote Therapeutics, Inc. BiotechnologyHealth Technology Antidote Therapeutics, Inc. engages in the provision of nicotine-blocking drugs to treat diseases caused or worsened by nicotine. Its product pipeline include ATI-1013, ATI 3009, and ATI-2000. The company was founded by Matthew Kalnik and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- Robert E. Ward
- Esperienza